Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hai-Kui Yang"'
Autor:
Rui-Qi Wang, Wei Zhao, Hai-Kui Yang, Jia-Mei Dong, Wei-Jie Lin, Fa-Zhong He, Min Cui, Zhi-Ling Zhou
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Colorectal cancer (CRC) manifests as gastrointestinal tumors with high intratumoral heterogeneity. Recent studies have demonstrated that CRC may consist of tumor cells with different consensus molecular subtypes (CMS). The advancements in single-cell
Externí odkaz:
https://doaj.org/article/c3fee79df1a54903a73211536d0a71db
Autor:
Hai-Kui Yang, Wei Zhao, Fazhong He, Rui-Qi Wang, Weijie Lin, Min Cui, Jia-Mei Dong, Zhiling Zhou
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Colorectal cancer (CRC) manifests as gastrointestinal tumors with high intratumoral heterogeneity. Recent studies have demonstrated that CRC may consist of tumor cells with different consensus molecular subtypes (CMS). The advancements in single-cell
Autor:
Rui-Qi, Wang, Fa-Zhong, He, Qian, Meng, Wei-Jie, Lin, Jia-Mei, Dong, Hai-Kui, Yang, Yang, Yang, Min, Zhao, Wen-Tao, Qiu, Yong-Jie, Xin, Zhi-Ling, Zhou
Publikováno v:
Ann Transl Med
BACKGROUND: Tribble pseudokinase 3 (TRIB3) plays a key role in regulating the malignancy of many tumors. This study examined its function in cancer cells and explored the potential mechanisms of action. METHODS: The expression of TRIB3 was examined i
Autor:
Lishun Zhang, Jiajie Zhang, Zhonghuang Li, Tingting Zhang, Xuan Xu, Shaoyu Wu, Zichao Yang, Shanhe Wan, Huiwu Zhang, Hai-Kui Yang, Yangcheng Ai
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 152
In this paper, we designed and synthesized two analog compounds M1 and T1 that have a Michael acceptor warhead. Although only slightly diversity existed in the structures of M1 and T1, their inhibitory activities against wild type epidermal growth fa
Publikováno v:
Future Medicinal Chemistry. 10:1705-1720
The abnormal expression of c-ros oncogene1 receptor tyrosine kinase (ROS1) has been identified as clinically actionable oncogenic driver in non-small-cell lung cancer. Since crizotinib was approved by the US FDA for the treatment of advanced ROS1-pos
Publikováno v:
ChemistryOpen. 7:447-456
The peptide segment of prostatic acid phosphatase (PAP248-286) aggregates to form SEVI (semen-derived enhancer of virus infection) amyloid fibrils. These are characteristic seminal amyloids that have the ability to promote the effect of HIV infection
Autor:
Wentao Qiu, Fazhong He, Qian Meng, Zhiling Zhou, Jia-Mei Dong, Hai-Kui Yang, Rui-Qi Wang, Yong-Jie Xin, Yang Yang, Min Zhao, Weijie Lin
Publikováno v:
Annals of Translational Medicine. 9:1253-1253
Background Tribble pseudokinase 3 (TRIB3) plays a key role in regulating the malignancy of many tumors. This study examined its function in cancer cells and explored the potential mechanisms of action. Methods The expression of TRIB3 was examined in
Publikováno v:
Chemical Papers. 72:651-659
As an aspect of our ongoing research on developing novel antiproliferative agents, 31 new triazole–isoindoline hybrids bearing 3,4,5-trimethoxyphenyl moiety were synthesized and evaluated for their antiproliferative activity against four cancer cel
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:3954-3958
Based on our previous work, a series of novel 2-amino-7,8-dihydropteridin-6(5H)-one derivatives were designed and synthesized via a ring-closing strategy. Biological evaluation with four human cancer cell lines (BT549, T47D, MDA-MB-468, and MDA-MB-23
Publikováno v:
European Journal of Medicinal Chemistry. 125:1098-1106
Thirty-two novel 3-alkylsulfanyl-1,2,4-triazole derivatives, designed as cis-restricted combretastatin A-4 analogues, were synthesized and evaluated for their antiproliferative activities. The results indicated that analogue 20 showed more potent ant